SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (733)6/23/2005 8:12:35 AM
From: nigel bates  Respond to of 1022
 
>>Abgenix claims....To date, scientists from both Lexicon and Abgenix have selected 13 human antigens...<<

That dates back to early 2001
Message 15275331
...announced today that LEXICON has delivered to Abgenix, thirteen (13) human antigens for antibody development as part of the companies' drug discovery alliance. This marks the first of many antigens to be delivered to Abgenix for the discovery of antibody-based drugs.

>>because they feel Xoma can give them better antibodies<<

Possibly: Xoma has the right to use several different companies' systems.

>>...because they wanted to tap into XOMA's development expertise?<<

You're joking ? <g>